RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/F21A080CC76DE39D454C71645142E8FD5D4544A5109122E6965C278734637FD75A83A22177431EBE099EB85D79E4C8BBhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F21A080CC76DE39D454C71645142E8FD5D4544A5109122E6965C278734637FD75A83A22177431EBE099EB85D79E4C8BBhttp://www.w3.org/2000/01/rdf-schema#comment"The level of HE4 in ovarian cancer ascites may reflect the therapeutic effect of ovarian cancer patients and a high level of HE4 might predict chemoresistance and the possibility of ascites formation. The determination of the expression of HE4 alone or combined with CA125 levels in both serum and ascites in ovarian cancer patients with ascites may have important significance for guiding and improving the treatment"xsd:string
http://purl.uniprot.org/uniprot/#_9AB28455B647ED5BBF287BD305D2ED374118F193E71CB323D579CE3612609C8B950E980E8DF2D4E0FE2111456F834383http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/F21A080CC76DE39D454C71645142E8FD5D4544A5109122E6965C278734637FD75A83A22177431EBE099EB85D79E4C8BB
http://purl.uniprot.org/uniprot/B3KY81http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/F21A080CC76DE39D454C71645142E8FD5D4544A5109122E6965C278734637FD75A83A22177431EBE099EB85D79E4C8BB
http://purl.uniprot.org/uniprot/#_B3KY81-mappedCitation-29903044http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/F21A080CC76DE39D454C71645142E8FD5D4544A5109122E6965C278734637FD75A83A22177431EBE099EB85D79E4C8BB